Pluripotent Stem Cell-Based Approaches to Explore and Treat Optic Neuropathies

Area of Science:

• Ophthalmology
• Neuroscience
• Regenerative Medicine

Background:

• Retinal degenerative diseases cause irreversible blindness, often involving specific cell loss like retinal ganglion cells (RGCs).
• Optic neuropathies, such as glaucoma, frequently affect RGCs, posing significant challenges for vision restoration therapies.
• Current cell replacement strategies for optic neuropathies face hurdles including cell survival, differentiation, and neural reconnection.

Purpose of the Study:

• To review the feasibility of stem cell-based strategies for RGC replacement in optic nerve impairment.
• To discuss methods for generating, characterizing, and delivering transplantable RGCs derived from pluripotent stem cells.
• To explore the utility of pluripotent stem cell-derived retinal organoids and RGCs for disease modeling and drug screening in optic neuropathies.

Main Methods:

• Review of current literature on stem cell-based therapies for retinal ganglion cells.
• Discussion of pluripotent stem cell reprogramming and differentiation techniques for RGC generation.
• Analysis of challenges and advancements in cell delivery and neural integration for optic neuropathies.

Main Results:

• Pluripotent stem cells provide a viable source for generating therapeutic RGCs.
• Strategies for RGC generation, characterization, and delivery are advancing.
• Retinal organoids and RGCs derived from pluripotent stem cells show promise for disease modeling and drug screening.

Conclusions:

• Stem cell-based strategies hold potential for treating optic neuropathies by replacing lost RGCs.
• Overcoming challenges in cell integration and central nervous system regeneration is crucial for clinical success.
• Pluripotent stem cell-derived models are valuable tools for understanding optic neuropathies and developing new treatments.